Skip to main content
Screener/Healthcare/Medical - Diagnostics & Research

CRL — Charles River Laboratories International, Inc.

NYSE
$165.56-1.52 (-0.91%)
S&P 500Mid CapHealthcareHigh Beta
$113.89
$228.39
$163.09
$167.66
EPS (TTM)$-2.96
P/E Ratio-56.87
Dividend Yield—
Market Cap$8.24B
Volume357K
Prev Close$166.97
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$994.2M-$276.6M$-5.6231.0%-27.8%
Q3 '25$1.0B$54.4M$1.1033.7%5.4%
Q2 '25$1.0B$52.3M$1.0634.6%5.1%
Q1 '25$984.2M$25.5M$0.5032.3%2.6%
Q4 '24$1.0B-$215.7M$-4.2228.4%-21.5%
Q3 '24$1.0B$68.7M$1.3334.6%6.8%
Q2 '24$1.0B$90.0M$1.7434.5%8.8%
Q1 '24$1.0B$67.3M$1.3034.1%6.7%
Get Your Daily Market Recap